Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T4996 |
Atosiban
阿托西班,RWJ22164,RW22164 |
Oxytocin Receptor; Vasopressin Receptor | Endocrinology/Hormones; GPCR/G Protein |
Atosiban (RW22164) 是一种脱氨基催产素类似物,是一种九肽,也是竞争性的催产素受体拮抗剂。它是一种宫缩抑制剂,可用于自发早产的研究。 | |||
T5148 |
Atosiban acetate
RW22164,Atosiban acetate (90779-69-4 free base),RWJ22164,醋酸阿托西班 |
Oxytocin Receptor; Vasopressin Receptor | Endocrinology/Hormones; GPCR/G Protein |
Atosiban acetate (RW22164) 是一种脱氨基催产素类似物,是一种九肽,也是竞争性的催产素受体拮抗剂。它是一种宫缩抑制剂,可用于自发早产的研究。 | |||
T28855 |
SSR126768A
SSR-126768A,SSR 126768A |
Oxytocin Receptor | Endocrinology/Hormones; GPCR/G Protein |
SSR126768A 是一种新型且具有选择性、口服活性和有效性的催产素(OT)受体拮抗剂,对子宫收缩有抑制作用,可用于预防早产。 | |||
T70570 | Erlosiban | ||
Erlosiban, also known as OBE001, is a novel, orally active nonpeptide oxytocin receptor antagonist under development for the treatment of preterm labor and improvement in embryo implantation and pregnancy rate in assisted reproductive technology (ART). | |||
T70000 |
Ebopiprant HCl
|
||
Ebopiprant, also known as OBE-022, is an Oral and Selective Prostaglandin F 2α Receptor Antagonist as an Effective and Safe Modality for the Treatment of Preterm Labor. OBE022 exhibits potent tocolytic effects on human tissues ex vivo and animal models in vivo without causing the adverse fetal side effects seen with indomethacin. | |||
T73762 |
11,12-DiHETrE
|
||
11,12-DiHETrE,一种细胞色素P450 (P450) 类二十烷素内源性代谢产物,用于早产研究,并可作为区分NAFL(非酒精性脂肪肝)与NASH(非酒精性脂肪性肝炎)的生物标志物。 | |||
T76565 |
PDC31
|
||
PDC31 (THG113.31; ILGHXDYK) 是FPProstaglandin Receptor 的变构和非竞争性抑制剂。PDC31是基于D-氨基酸的寡肽,用作平滑肌收缩剂。PDC31 在体内降低子宫收缩的强度和持续时间,可用于早产和原发性痛经 (PD) 的研究。PDC31 还增强人子宫肌层细胞中 Ca2+依赖性大电导 K+通道。 |